Business Standard

Strides Pharma to set up 800-mn capacity vaccine suite in Bengaluru

In talks with global players seeking manufacturing opportunity for potential Covid-19 vaccine

Vaccine, Covid
Premium

The vaccine suite will have the capacity to manufacture 500 million doses of liquid vaccine and 300 million doses of Lyophilised vaccines annually.

Samreen Ahmad Bengaluru
Eyeing the vaccine opportunity created by the Covid-19 pandemic, Strides Pharma Science is in the process of setting up a vaccine suite in Bengaluru, said a top company official. The vaccine lines are a part of the $40 million investment that the company had committed for its associate Stelis Biopharma.

“Existing vaccine capacities globally are not sufficient to cater to the entire global population and there is going to be high demand,” said R Ananthanarayanan, managing director & chief executive officer of the Bengaluru-headquartered pharma company.

Strides is in discussions with all the global players who are in advanced stages

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 29 2020 | 7:50 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com